Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bellagamba

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
International Journal of STD & AIDS|July 31, 2012
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factorsR Bucciardini, G D'Ettorre, S Baroncelli, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimenD Armenia, D Di Carlo, A Calcagno, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2020
HIV MDR is still a relevant issue despite its dramatic drop over the yearsD Armenia, D Di Carlo, P Flandre, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
International Journal of STD & AIDS|July 31, 2012
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factorsR Bucciardini, G D'Ettorre, S Baroncelli, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimenD Armenia, D Di Carlo, A Calcagno, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2020
HIV MDR is still a relevant issue despite its dramatic drop over the yearsD Armenia, D Di Carlo, P Flandre, et al.
Pageof 3